diabetes mellitus

A RANDOMIZED COMPARATIVE CLINICAL TRIAL TO EVALUATE THE EFFECT OF VAMANA KARMA AND VIRECHANA KARMA IN THE MANAGEMENT OF APATHYANIMITTAJA MADHUMEHA W.S.R TO TYPE 2 DIABETES MELLITUS - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/098119

Enrollment

Registered

2025-11-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with clinical features of madhumeha T2DM will be selected Patients with FBS 150 to 250mg per dl and PPBS 200to 350mg per dl Patients with HbA1c 6 to 10 percentage Patients of either sex between the age group of 25 to 60 years Patients who will sign for informed consent Patients who are fit for Snehapana Vamana karma Virechana karma

Exclusion criteria

Exclusion criteria: Patients of Type I DM Patients with diabetic complications like nephropathy neuropathy retinopathy Pregnancy and Lactating women Patients with severe systemic disorders like Cardiovascular Renal HTN etc

Design outcomes

Primary

Measure	Time frame
1 Changes in FBS and PPBS level 2 Relief from subjective parametersTimepoint: 4 weeks	—

Secondary

Measure	Time frame
Prevention of diabetic complicationsTimepoint: 4 weeks	—

Countries

India

Contacts

Public ContactDr Rajesh Sugur

Taranath Government Ayurveda Medical college and hospital

vdrsugur@gmail.com9844457833

Outcome results